Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Healthpeak Properties Inc V.DOC


Primary Symbol: DOC

Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT). The Company acquires, develops, owns, leases, and manages healthcare real estate across the United States. Its strategy is to invest in and manage real estate focused on healthcare discovery and delivery. It has a diversified portfolio of high-quality healthcare properties across three core asset classes of lab, outpatient medical, and continuing care retirement community (CCRC) real estate. The Company’s segments include Lab, Outpatient medical and CCRC. The lab segment properties contain laboratory and office space, are leased primarily to biotechnology, medical device and pharmaceutical companies, scientific research institutions, government agencies, and other organizations involved in the life science industry. The Outpatient Medical segment includes outpatient medical buildings and hospitals. Outpatient medical buildings typically contain physicians’ offices and examination rooms.


NYSE:DOC - Post by User

Post by slowcookon Oct 22, 2021 10:26am
315 Views
Post# 34037106

Q3 release date

Q3 release date
I would guess most of us that have been with cloudmd do pay attention to Q3 results and date.
Q3 2020 was released on November 30.. so we still have long way to go.
Q3 should have positive ebitda and significant move up.

Now, Q3 has wrapped up on Sept 30., and there's nothing that should stop Cloudmd to keep rolling with acquisitions.. and they have enough cash for that. I hope they are waiting q3 and stock to move to new base.. and it would significantly help them with new acquisitions and somewhat easier share dilution.
No question lack of news with organic growth is disappointing.

There's always good portion of pain when the insiders in the company have such small portion of stocks.  Definetly, not the same as the case when they have at least 10%.

I have sizeble investment here.. in couple of accounts. In avg. 25% in red!

<< Previous
Bullboard Posts
Next >>